The invention is a silicon substituted oxyapatite compound (Si--OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca.sub.5(PO.sub.4).sub.3-x(SiO.sub.4).sub.xO.sub.(1-x)/2, where 0